sb 203580 has been researched along with azetidyl-2-carboxylic acid in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (azetidyl-2-carboxylic acid) | Trials (azetidyl-2-carboxylic acid) | Recent Studies (post-2010) (azetidyl-2-carboxylic acid) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 600 | 49 | 219 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, S; Komatsubara, AT; Kyotani, Y; Nagayama, K; Ozawa, K; Tsuji, Y; Yoshizumi, M; Zhao, J | 1 |
1 other study(ies) available for sb 203580 and azetidyl-2-carboxylic acid
Article | Year |
---|---|
Azelnidipine inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch.
Topics: Animals; Anthracenes; Antioxidants; Aorta; Azetidinecarboxylic Acid; Blood Pressure; Cells, Cultured; Dihydropyridines; Enzyme Inhibitors; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Onium Compounds; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley | 2014 |